The topics for discussion include:
- Patent legislation, both from the standpoint of a critical analysis of pending bills and whether other legislation may better reach the results sought;
- Section 101 patent eligibility after Bilski, Prometheus, and Myriad; the law of obviousness post KSR;
- De novo review of claim construction rulings;
- The implications of the Medtronic case now before the Supreme Court on patent licensing in the wake of Medimmune;
- The impact of the Federal Circuit’s decision in Fresenius v. Baxter on patent validity challenges; and
- The ITC’s domestic industry requirement; and proposed reform of appellate jurisdiction in patent cases.
Related Insights
December 23, 2025
Energy Current
FERC Opens New Paths for Co-Located Loads in PJM: What Data Center and Power Generation Developers Need to Know
Key Takeaways FERC has ordered PJM to overhaul its tariff framework for co-located generation and large loads, finding existing rules…
December 23, 2025
Foley Viewpoints
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Key Points: PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold…
December 23, 2025
Tariff & International Trade Resource
Grandma Got Audited by a Reindeer
So…it’s Christmastime. Which can only mean it’s time for the Christmas tradition that everyone has been waiting for all year…our annual holiday compliance parody article!